logo-loader
MaxCyte Inc - MaxCyte offering exposure to 'explosive growth' in cell therapy and cellular engineering
on 5/12/19
Ipsen - Open Orphan 'continuing to target rapid scale-up and profitability'
on 5/12/19
gene
on 26/11/19
life sciences
on 25/11/19
Shield Therapeutics PLC - Shield Therapeutics: Analyst discusses further positive data from non-inferiority Feraccru study
on 31/10/19
ferracru
on 29/10/19
Exactus, Inc - Exactus Inc 'targeting the highest-growth segments of the CBD market'
on 29/10/19
Cannabis
on 24/10/19
Avacta Group PLC - Avacta Group heading into 'crucial year' for its cancer therapeutics programmes
on 23/10/19
Cannabis
on 7/10/19
BevCanna Enterprises Inc - BevCanna Enterprises taking advantage of CBD beverages market
on 7/10/19
BevCanna Enterprises Inc - BevCanna Enterprises taking advantage of CBD-infused beverages market
on 7/10/19
Open Orphan - Open Orphan PLC targeting 'value creation and rapid scale-up'
on 20/8/19
Broad label approval is 'best possible outcome' for Shield Therapeutics' Feraccru
on 5/8/19
DNA
on 29/7/19
SHIELD_THERAPEUTICS_emma.jpg
on 10/5/19
anemia
on 9/5/19
Capture-Ed-Avact-JPG.jpg
on 9/4/19
healthcare
on 9/4/19
Riccardo-Shields-picture.jpg
on 21/1/19